Key result
Induced pluripotent stem cell-derived cardiomyocytes provide a robust platform to study arrhythmic disorders and advance the science and clinical care of sudden cardiac death.
Induced pluripotent stem cell-derived cardiomyocytes offer a valuable and robust platform for modeling and studying arrhythmic disorders that lead to sudden cardiac death.
Answers are grounded in this paper and cite their sources.
Supports iPSC-CM arrhythmia modeling; leaves open clinical translation to sudden cardiac death prevention.
Sudden cardiac death is a common cause of death in patients with structural heart disease, genetic mutations, or acquired disorders affecting cardiac ion channels. A wide range of platforms exist to model and study disorders associated with sudden cardiac death. Human clinical studies are cumbersome and are thwarted by the extent of investigation that can be performed on human subjects. Animal models are limited by their degree of homology to human cardiac electrophysiology, including ion channel expression. Most commonly used cellular models are cellular transfection models, which are able to mimic the expression of a single-ion channel offering incomplete insight into changes of the action potential profile. Induced pluripotent stem cell-derived cardiomyocytes resemble, but are not identical, adult human cardiomyocytes and provide a new platform for studying arrhythmic disorders leading to sudden cardiac death. A variety of platforms exist to phenotype cellular models, including conventional and automated patch clamp, multielectrode array, and computational modeling. Induced pluripotent stem cell-derived cardiomyocytes have been used to study long QT syndrome, catecholaminergic polymorphic ventricular tachycardia, hypertrophic cardiomyopathy, and other hereditary cardiac disorders. Although induced pluripotent stem cell-derived cardiomyocytes are distinct from adult cardiomyocytes, they provide a robust platform to advance the science and clinical care of sudden cardiac death.
No takes yet. Share an insight, caveat, or question.
Sallam et al. (2015) conducted a review in Sudden cardiac death. Induced pluripotent stem cell-derived cardiomyocytes was evaluated. Induced pluripotent stem cell-derived cardiomyocytes provide a robust platform to study arrhythmic disorders and advance the science and clinical care of sudden cardiac death.
Synapse has enriched 10 related papers. Consider them for comparative context: